Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 7/20 | 0.42 |
| ▸ | CES1 | P23141 | 5/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 6/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL664815 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL1697656 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL83980 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL4854234 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL23034519 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL11245966 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL24234728 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL6934289 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL22268768 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB | |
| SCHEMBL4434277 | 1.00 | CES2 (0.50) | CES2LPAR1LPAR3TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117160497-B | Catalyst and method for preparing hexafluoropropylene dimer | 北京宇极科技发展有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-117258208-A | Fire extinguishing agent suitable for lithium battery fire fighting and preparation method thereof | 中船九江海洋装备(集团)有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-117160497-A | Catalyst and method for preparing hexafluoropropylene dimer | 北京宇极科技发展有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-117138836-A | Oxide/iodine composite particles and dispersion of oxide/iodine composite particles | 中国石油化工股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-115466601-B | Fluorine-containing electronic cooling liquid | 北京宇极科技发展有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-115466601-A | Fluorine-containing electronic cooling liquid | 北京宇极科技发展有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-110740813-A | Systems and methods involving continuous flow droplet reactions | 亚利桑那州立大学董事会 | 2020-01-31 | — | — | CN | claimed |
| EP-3544737-A1 | SYSTEMS AND METHODS RELATED TO CONTINUOUS FLOW DROPLET REACTION | Arizona Board of Regents on behalf of Arizona State University (US) | 2019-10-02 | — | — | EP | claimed |
| US-20190291114-A1 | SYSTEMS AND METHODS RELATED TO CONTINUOUS FLOW DROPLET REACTION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY | 2019-09-26 | — | — | US | claimed |
| WO-2018098438-A1 | SYSTEMS AND METHODS RELATED TO CONTINUOUS FLOW DROPLET REACTION | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-05-31 | — | — | WO | claimed |
| JP-2202851-A | — | — | None | — | — | JP | disclosed |
| JP-9309864-A | — | — | None | — | — | JP | disclosed |
| US-12390437-B2 | Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response | SITRYX THERAPEUTICS LIMITED (GB) | 2025-08-19 | — | — | US | disclosed |
| US-12350672-B2 | Systems and methods related to continuous flow droplet reaction | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2025-07-08 | — | — | US | disclosed |
| EP-3544737-B1 | METHODS RELATED TO CONTINUOUS FLOW DROPLET REACTION | UNIV ARIZONA STATE (US) | 2025-04-23 | — | — | EP | disclosed |
| EP-0485479-A1 | PERFLUORO-T-BUTYL-CONTAINING COMPOUNDS FOR USE IN FLUORINE-19 NMR AND/OR MRI. | UNIV JOHNS HOPKINS (US) | 1992-05-20 | — | — | EP | disclosed |
| WO-1991001759-A1 | PERFLUORO-T-BUTYL-CONTAINING COMPOUNDS FOR USE IN FLUORINE-19 NMR AND/OR MRI | THE JOHNS HOPKINS UNIVERSITY (US) | 1991-02-21 | — | — | WO | disclosed |
| EP-0409634-A2 | Liquid crystal compounds and optically active compounds | SANYO CHEMICAL INDUSTRIES LTD. (JP) | 1991-01-23 | — | — | EP | disclosed |
| JP-H02202851-A | OPTICALLY ACTIVE COMPOUND, FERROELECTRIC LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME AND LIQUID CRYSTAL ELEMENT THEREOF | SHARP CORP | 1990-08-10 | — | — | JP | disclosed |
| EP-0355772-A2 | Liquid-crystalline copolymer | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1990-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12390437-B2 | Itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response | IL1R1, IL1B, IL1A | CES2 4674/4885LPAR1 1422/4885LPAR3 3742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.